Shannon E. Lynch
Impact in
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 6
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Matthew Ryan Smith (1 shared paper)Anna G. Sorace (9 shared papers)Yun Lü (3 shared papers)Suzanne E. Lapi (6 shared papers)Jason M. Warram (2 shared papers)Jim Q. Ho (1 shared paper)Mohammad Reza Sepand (1 shared paper)Fang Jia (2 shared papers)
- Journals
- Scientific Reports (3 papers)Cancers (1 paper)Neoplasia (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Theranostics (1 paper)
- Partner nations
- United StatesMexico
In The Last Decade
Shannon E. Lynch
8 papers receiving 60 citations
Peers
Comparison fields: 5 of 43
- Oncology 18
- Immunology 12
- Radiology, Nuclear Medicine and Imaging 10
- Sensory Systems 2
- Cancer Research 5
Countries citing papers authored by Shannon E. Lynch
This map shows the geographic impact of Shannon E. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon E. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon E. Lynch more than expected).
Fields of papers citing papers by Shannon E. Lynch
This network shows the impact of papers produced by Shannon E. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon E. Lynch. The network helps show where Shannon E. Lynch may publish in the future.
Co-authors
The 25 scholars most cited alongside Shannon E. Lynch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 21 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 7 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2025 | 2 | |
| 9 | 2025 | 0 | |
| 10 | 2025 | 0 | |
| 11 | 2025 | 0 |
About Shannon E. Lynch
Shannon E. Lynch is a scholar working on Oncology, Epidemiology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 11 papers that have together received 62 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), CAR-T cell therapy research (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Diet and metabolism studies (1 paper), Ion channel regulation and function (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Oncology (18 citations), Immunology (12 citations), Radiology, Nuclear Medicine and Imaging (10 citations), Sensory Systems (2 citations) and Cancer Research (5 citations). Shannon E. Lynch has collaborated with scholars based in United States and Mexico. Frequent co-authors include Matthew Ryan Smith, Anna G. Sorace, Yun Lü, Suzanne E. Lapi, Jason M. Warram, Jim Q. Ho, Mohammad Reza Sepand, Fang Jia, Saeid Zanganeh and Alessandro Mascioni. Their work appears in journals such as Scientific Reports, Cancers, Neoplasia, Frontiers in Cell and Developmental Biology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.